Ryuvidine

CAS No. 265312-55-8

Ryuvidine( SPS8I-2 )

Catalog No. M13813 CAS No. 265312-55-8

Ryuvidine is a potent, selective CDK4 inhibitor with IC50 of 6.0 uM, displays >30-fold selectivity over CDK2 (IC50>100 uM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 141 In Stock
10MG 207 In Stock
25MG 353 In Stock
50MG 511 In Stock
100MG 728 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Ryuvidine
  • Note
    Research use only, not for human use.
  • Brief Description
    Ryuvidine is a potent, selective CDK4 inhibitor with IC50 of 6.0 uM, displays >30-fold selectivity over CDK2 (IC50>100 uM).
  • Description
    Ryuvidine is a potent, selective CDK4 inhibitor with IC50 of 6.0 uM, displays >30-fold selectivity over CDK2 (IC50>100 uM); shows potent cytototoxic activity against HL-60, A549, Col 1, HepG2 cancer cell lines with IC50 of 0.3-1.2 ug/mL; also inhibits SETD8 with IC50 of 0.5 uM, efficiently and selectively suppresses cellular H4K20me1 at doses lower than 5 uM.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    SPS8I-2
  • Pathway
    Angiogenesis
  • Target
    CDK
  • Recptor
    CDK
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    265312-55-8
  • Formula Weight
    284.3
  • Molecular Formula
    C15H12N2O2S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC1=NC2=C(C(C=C(NC3=CC=C(C)C=C3)C2=O)=O)S1
  • Chemical Name
    2-methyl-5-[(4-methylphenyl)amino]-4,7-benzothiazoledione

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Blum G, et al. ACS Chem Biol. 2014 Nov 21;9(11):2471-8. 2. Ryu CK, et al. Bioorg Med Chem Lett. 2000 Mar 6;10(5):461-4. 3. Lang E, et al. Cell Physiol Biochem. 2015;37(3):1178-86.
molnova catalog
related products
  • Kenpaullone

    Kenpaullone (9-Bromopaullone,NSC-664704) is a potent inhibitor of CDK1/cyclin B with IC50 of 0.4 uM, also inhibited CDK2/cyclin A (IC50=0.68 uM), CDK2/cyclin E (IC50-7.5 uM) and CDK5/p25 (IC50=0.85 uM).

  • NVP-LCQ195

    NVP-LCQ195 (AT9311) is a potent inhibitor of CDK1, CDK2, CDK3 and CDK5 (IC50: 1-42 nM).

  • Dalpiciclib

    Dalpiciclib is a highly selective, orally bioavailable, and comparable potency inhibitor of CDK4 and CKD6 with IC50s of 12.4?nM and 9.9?nM, respectively.